Related Experiment Videos
Erythrocyte 2,3-diphosphoglycerate in diabetes and renal disease
Journal of Clinical Pathology
|November 1, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?
Tropical medicine & international health : TM & IH·2011
Mapping trachoma in Nasarawa and Plateau States, central Nigeria.
The British journal of ophthalmology·2010
Evaluation of the prevalence of trachoma 12 years after baseline surveys in Kidal Region, Mali.
Tropical medicine & international health : TM & IH·2010
Flies and Helicobacter pylori infection.
Archives of disease in childhood·2004
Changes in house design reduce exposure to malaria mosquitoes.
Tropical medicine & international health : TM & IH·2003
Human and other faeces as breeding media of the trachoma vector Musca sorbens.
Medical and veterinary entomology·2001
Deep learning techniques in predicting BRAF mutation status in cutaneous melanoma from histopathologic images.
Journal of clinical pathology·2026
ALK overexpression without rearrangement widely exists in EWSR1/FUS-rearranged soft tissue tumours.
Journal of clinical pathology·2026
Adapt or Become Irrelevant: the Pathologist as the new Diagnostic Architect.
Journal of clinical pathology·2026
Targeted transcriptome profiling of oral cavity squamous cell carcinoma and histologic grade-associated gene expression patterns.
Journal of clinical pathology·2026
Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology.
Therapeutic advances in endocrinology and metabolism·2026
Key Experimental Therapeutics and Knowledge Gaps in Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Drug design, development and therapy·2026
Evaluation of muscle microvascular perfusion in primary mitochondrial disease by contrast-enhanced ultrasound: Feasibility study.
Therapeutic advances in rare disease·2026